Financhill
Sell
48

CHGCY Quote, Financials, Valuation and Earnings

Last price:
$21.34
Seasonality move :
5.82%
Day range:
$20.38 - $22.04
52-week range:
$14.52 - $26.00
Dividend yield:
1.28%
P/E ratio:
27.29x
P/S ratio:
9.28x
P/B ratio:
5.57x
Volume:
145K
Avg. volume:
114.3K
1-year change:
13.39%
Market cap:
$70.2B
Revenue:
$7.9B
EPS (TTM):
$0.78

Earnings Data

Next earnings date for CHGCY
Jan 31
2025
Most recent earnings per share
$0.22
Beat by $0.22
(Oct 25/2024)
Consensus Estimate
--
(Oct 25/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CHGCY Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
10/25/2024 Q3 -- $2.1B $0.22 -- --
07/25/2024 Q2 -- $2B $0.22 -- --
04/24/2024 Q1 -- $1.6B $0.15 -- --
02/01/2024 Q4 -- $1.9B $0.19 -- --
10/24/2023 Q3 -- -- $0.16 -- --
07/27/2023 Q2 -- -- $0.18 -- --
04/27/2023 Q1 -- -- $0.17 -- --
12/31/2022 Q4 -- -- $0.22 -- --
10/24/2022 Q3 -- -- $0.15 -- --
07/21/2022 Q2 -- -- $0.17 -- --
04/25/2022 Q1 -- -- $0.34 -- --
02/03/2022 Q4 -- -- $0.26 -- --
10/22/2021 Q3 -- -- $0.24 -- --
07/26/2021 Q2 -- -- $0.20 -- --
04/22/2021 Q1 -- -- $0.14 -- --
02/04/2021 Q4 -- -- $0.15 -- --
10/22/2020 Q3 -- -- $0.17 -- --
07/27/2020 Q2 -- -- $0.14 -- --
04/23/2020 Q1 -- -- $0.14 -- --
01/30/2020 Q4 -- -- $0.11 -- --
10/24/2019 Q3 -- -- $0.14 -- --
07/25/2019 Q2 -- -- $0.09 -- --
04/24/2019 Q1 -- -- $0.10 -- --
01/31/2019 Q4 -- -- $0.06 -- --
10/24/2018 Q3 -- -- $0.06 -- --
07/26/2018 Q2 -- -- $0.06 -- --
04/24/2018 Q1 -- -- $0.08 -- --
02/01/2018 Q4 -- -- $0.04 -- --
10/25/2017 Q3 -- -- $0.06 -- --
07/27/2017 Q2 -- -- $0.05 -- --
04/25/2017 Q1 -- -- $0.05 -- --
02/01/2017 Q4 -- -- $0.03 -- --
10/25/2016 Q3 -- -- $0.03 -- --
07/21/2016 Q2 -- -- $0.05 -- --
03/31/2016 Q1 -- -- $0.04 -- --
12/31/2015 Q4 -- -- $0.03 -- --
10/22/2015 Q3 -- -- $0.04 -- --
07/24/2015 Q2 -- -- $0.04 -- --
04/22/2015 Q1 -- -- $0.04 -- --
01/29/2015 Q4 -- -- $0.03 -- --

Chugai Pharmaceutical Earnings Questions

  • How Much did Chugai Pharmaceutical Generate in Revenue Last Quarter?

    Chugai Pharmaceutical reported $2.1B worth of top line sales in its most recent quarter.

  • Did Chugai Pharmaceutical Beat Earnings Last Quarter?

    Chugai Pharmaceutical announced earnings per share of $0.22 which represents a beat of analyst forecast a -- per share.

  • Is Chugai Pharmaceutical Profitable?

    Chugai Pharmaceutical reported $1.6B that represents $0.47 per share over the last quarter.

  • What is the Analyst Consensus for Chugai Pharmaceutical EPS Next Year?

    Chugai Pharmaceutical's earnings are forecast to grow from $0.70 per share to -- per share next year representing an increase of --.

  • When is Chugai Pharmaceutical's Earnings Date?

    Chugai Pharmaceutical's next earnings date is January 31, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock